Uterus Transplantation LD - Feasibility Study - Sahlgrenska - BMC
NCT ID: NCT03590405
Last Updated: 2021-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2018-06-15
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Theory and common animal workshops have been ongoing for 3 years. The team from Bellevue Medical Centre is affiliated to St Joseph, University, Beirut
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
uterus transplantation
uterus transplantation from living donor with the donor being close relative
uterus transplantation surgery and IVF
IVF before surgery living donor uterus transplantation ET
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uterus transplantation surgery and IVF
IVF before surgery living donor uterus transplantation ET
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* psychologicaly stable
* BMI \< 35
* no systemic disease
* no standing medication
* in a stable relationship or married
* normal ovarian reserve
* absolute uterine factor infertility
* normal kidney function
* close relative to recipient
* age \< 60 years
* normal pregnancies
* maximum two cesarean sections
* BMI \< 35
* no major systemic disease
* no previous major surgery
18 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint Joseph University, at Bellevue Medical Centre
UNKNOWN
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mats Brännström
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mats Brännström, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, , Sweden
Mats Brännström
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sahlgrenska-BMC-UTx
Identifier Type: -
Identifier Source: org_study_id